Growth Hormone Did Not Enhance Mucosal Hyperplasia after Small-Bowel Resection

References

• Kopple J D. The rationale for the use of growth hormone or insulin-like growth factor I in adult patients with renal failure. Miner Electrolyte Metab 1992; 18: 269–75
   PubMedGoogle Scholar
• Daughaday W H, Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentration. Endocr Rev 1989; 10: 68–91
   PubMed Web of Science ®Google Scholar
• Park J HY, McCusker R H, Vanderhoof J A, Mohammadpour H, Harty R F, MacDonald R G. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology 1992; 131: 1359–68
   PubMed Web of Science ®Google Scholar
• Lemmey A B, Martin A A, Read L C, Tomas F M, Owens P C, Ballard F J. IGF-I and the truncated analogues des-(1–3)-IGF-I enhance growth in rats after gut resection. Am J Physiol 1991; 260: E213–9, (Endocrinol Metab 23)
   PubMedGoogle Scholar
• Vanderhoof J A, McCusker R H, Clark R, Mohammadpour H, Blackwood D J, Harty R F, et al. Truncated and native insulin-like growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology 1992; 102: 1949–56
   PubMed Web of Science ®Google Scholar
• Rechler M M, Brown A L. Insulin-like growth factor binding proteins: gene structure and expression. Growth Reg 1992; 2: 55–68
   PubMedGoogle Scholar
• Clemmons D R. IGF binding proteins: regulation of cellular actions. Growth Reg 1992; 2: 80–7
   PubMedGoogle Scholar
• Johnson L R. Regulation of gastrointestinal growth. Physiology of the gastrointestinal tract, L Johnson. Raven Press, New York 1987; 169–96
   Google Scholar
• Baxter R C. The somatomedins: insulin-like growth factors. Adv Clin Chem 1986; 25: 49–112
   PubMed Web of Science ®Google Scholar
• Burgess E J. Insulin-like growth factor 1: a valid nutritional indicator during parenteral feeding of patients suffering an acute phase response. Ann Clin Biochem 1992; 29: 37–144
   Google Scholar
• Hill K K, Hill D B, McClain M P, Humphries L L, McClain C J. Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. J Am Coll Nutr 1993; 12: 475–8
   PubMed Web of Science ®Google Scholar
• Clemmons D R, Underwood L E, Dickerson N, Brown R O, Hak L J, MacPhee R D, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985; 41: 191–8
   PubMed Web of Science ®Google Scholar
• Isley W L, Underwood L E, Clemmons D R. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983; 71: 175–82
   PubMed Web of Science ®Google Scholar
• Scott C D, Baxter R C. Production of insulin-like growth factor-I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology 1986; 119: 2346–52
   PubMedGoogle Scholar
• Underwood L E, Clemmons D R, Maes M, D'Ercole A J, Ketelslegers J M. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm Res 1986; 24: 166–76
   PubMed Web of Science ®Google Scholar
• Grant D B, Hambley J, Becker D, Pimstone B E. Reduced sulfation factor in undernourished children. Arch Dis Child 1973; 48: 596–600
   PubMed Web of Science ®Google Scholar
• Maes M, Underwood L E, Ketelslegers J M. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. J Endocrinol 1983; 97: 243–51
   PubMed Web of Science ®Google Scholar
• Maes M, Underwood L E, Ketelslegers J M. Low serum somatomedin-C in protein deficiency: relationship with changes in liver somatogenic and lactogenic binding sites. Mol Cell Endocrinol 1984; 37: 301–9
   PubMed Web of Science ®Google Scholar
• Hintz R R, Suskind R, Amatayakul K, Thanangkul O, Olson R. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Pediatr 1978; 92: 153–6
   PubMed Web of Science ®Google Scholar
• Marks V, Howorth N, Greenwood F C. Plasma growth-hormone levels in chronic starvation in man. Nature 1965; 208: 686–7
   Web of Science ®Google Scholar
• Pimstone B E, Wittmann W, Hansen J DL, Murray P. Growth hormone and kwashiorkor. Lancet 1966; 2: 779–80
   PubMedGoogle Scholar
• Munro H N, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966; 91: 78–87
   PubMed Web of Science ®Google Scholar
• Giles K W, Myers A. Improved diphenylamine method for estimation of DNA. Nature 1965; 206: 93–4
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem 1964; 7: 18–25
   PubMed Web of Science ®Google Scholar
• Rivero F L, Goya L, Pascual-Leone A M. Comparison of extraction methods for insulin-like growth factor-binding proteins prior to measurement of insulin-like growth factor-I in undernourished neonatal and adult rat serum. J Endocrinol 1994; 140: 257–63
   PubMedGoogle Scholar
• McCusker R H, Cumacho-Hubner C, Clemmons D R. Identification of the types of insulin-like growth factor binding proteins that are secreted by muscle cells in vitro. J Biol Chem 1989; 264: 7775–80
   Google Scholar
• Steel R GD, Torrie J H. Principles and procedures of statistics. 2nd ed. McGraw-Hill, New York 1980
   Google Scholar
• Park J HY, McCusker R H, Mohammadpour H, Blackwood D J, Hrbek M, Vanderhoof J A. Dexamethasone inhibits mucosal adaptation after small bowel resection. Am J Physiol 1994; 266: 497–503, (Gastrointest Liver Physiol 29)
   PubMedGoogle Scholar
• Rechler M M, Nissley S P. Insulin-like growth factors. Peptide growth factors and their receptors I, M B Sporn, A B Robert. Springer-Verlag, Berlin 1990; 263–80
   Google Scholar
• Szabo L, Mottershead D G, Ballard F J, Wallace J C. The bovine insulin-like growth factor (IGF) binding purified from conditioned medium requires the N-terminal tripeptide in IGF-I for binding. Biochem Biophys Res Commun 1988; 151: 207–14
   PubMedGoogle Scholar
• Shulman D I, Hu C S, Duckett G, Lavallee-Grey M. Effects of short-term hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol 1992; 14: 3–11
   PubMedGoogle Scholar
• Herndon D N, Barrow R E, Kunkel K R, Broemeling L, Rutin R R. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 12: 424–31
   Google Scholar
• Domene H, Krishnamurthi K, Eshet R, Gilad I, Laron Z, Koch I, et al. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of Juvenile rats. Endocrinology 1983; 133: 675–82
   Google Scholar
• Leblond C P, Carriere R M. The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rats. Endocrinology 1955; 56: 261–6
   PubMedGoogle Scholar
• Albiston A L, Taylot R G, Herington A C, Beveridge D J, Fuller P J. Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: a novel mechanism to amplify IGF action. Mol Cell Endocrinol 1992; 83: R17–R20
   PubMedGoogle Scholar
• Peter M A, Winterhalter K H, Boni-Schnetzler M, Froesch E R, Zapf J. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat adipose tissue. Endocrinology 1993; 133: 2624–31
   PubMed Web of Science ®Google Scholar
• Luo J, Murphy L J. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rats. Endocrinology 1989; 125: 165–71
   PubMedGoogle Scholar
• Glasscock G F, Hein A N, Miller J A, Hintz R L, Rosenfeld R G. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine of growth hormone, on the neonatal hypophysectomized rats. Endocrinology 1992; 130: 203–10
   PubMed Web of Science ®Google Scholar
• Philips L S, Young H S. Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats. Endocrinology 1976; 99: 304–14
   PubMedGoogle Scholar
• Takano K, Hizuka N, Kawai K, Shizume K. Effect of growth hormone and nutrition on the level of somatomedin A in the rat. Acta Endocrinol (Copenh) 1978; 87: 485–94
   PubMedGoogle Scholar
• Shapiro B, Pimstone B L. Sulphation factor (somatomedin activity) in experimental protein malnutrition in the rat. J Endocrinol 1978; 77: 233–40
   PubMedGoogle Scholar
• Mares M, Amand Y, Underwood L E, Maiter D, Ketelslegers J M. Decreased serum insulin-like growth factor-I response to growth hormone in hypophysectomized rats fed a low protein diet: evidence for a postreceptor defect. Acta Endocrinol (Copenh) 1988; 117: 320–7
   PubMedGoogle Scholar
• Wood W I, Cachianes G, Henzel W J, Winslow C A, Spencer S A, Hellmiss R, et al. Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol Endocrinol 1988; 2: 1176–85
   PubMed Web of Science ®Google Scholar
• Shimasaki S, Uchiyama F, Shimonaka M, Ling N. Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol 1990; 4: 1451–58
   PubMedGoogle Scholar
• Zapf J, Bom W, Chang J Y, James P, Froesch E R, Fisher J A. Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. Biochem Biophys Res Commun 1988; 156: 1187–94
   PubMedGoogle Scholar